Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 94

Sort by

Sort Order Select

Journal Articles

Comparative safety and efficacy of bendamustine versus fludarabine/cyclophosphamide prior to chimeric antigen receptor- T cell therapy: A systematic review and meta-analysis

Muhammad Kashif Amin, Tehseen Raza, Hira Habib, Nabeeha Noor, Muhammad Usman, Fatima Imran, Rameen Fatima, Muhammad Zohaib Qasim, Hammad Shafi, Moazzam Shahzad, Joseph McGuirk, Muhammad Umair Mushtaq

Blood (2025) 146 (Supplement 1): 6320.

https://doi.org/10.1182/blood-2025-6320

Published: 2025

Journal Articles

Impact of early bacteremia on clinical outcomes following allogeneic hematopoietic cell transplantation with post-transplant cyclophosphamide-based gvhd prophylaxis

Moazzam Shahzad, Shah Rukh, Aroog Khaliq, Aqeeb Ur Rehman, Amna Bint I Munir, Muhammad Kashif Amin, Amir Kasaeian, Anthony Sung, Mehdi Hamadani, Joseph McGuirk, Muhammad Umair Mushtaq

Blood (2025) 146 (Supplement 1): 4200.

https://doi.org/10.1182/blood-2025-4200

Published: 2025

Journal Articles

Impact of donor age on transplant outcomes in unrelated allogeneic hematopoietic stem cell transplantation using post-transplant cyclophosphamide-based gvhd prophylaxis

Muhammad Kashif Amin, Moazzam Shahzad, Matthew McGuirk, Asma Zakir, Al-Ola Abdallah, Nausheen Ahmed, Sunil Abhyankar, Mehdi Hamadani, Joseph McGuirk, Muhammad Umair Mushtaq

Blood (2025) 146 (Supplement 1): 173.

https://doi.org/10.1182/blood-2025-173

Published: 2025

Journal Articles

Tumor-infiltrating lymphocyte therapy in lung cancer: A systematic review

Muhammad Kashif Amin, Muhammad Asad Shabbir, Nabeeha Noor, Abdullah Masood, Maham Rasool, Muhammad Ali Lak, Qasim Chohdry, Hammad Shafi, Ezza Bashir, Moazzam Shahzad, Joseph McGuirk, Muhammad Umair Mushtaq

Blood (2025) 146 (Supplement 1): 7692.

https://doi.org/10.1182/blood-2025-7692

Published: 2025

Journal Articles

Outcomes after bone marrow versus peripheral blood mismatched unrelated donor hematopoietic cell transplantation using posttransplant cyclophosphamide-based GVHD prophylaxis

Amir Kasaeian, Moazzam Shahzad, Zeeshan Sattar, Muhammad Kashif Amin, Hediyeh Alemi, Forat Lutfi, Mehdi Hamadani, Rajat Bansal, Alma Habib, Joseph McGuirk, Muhammad Umair Mushtaq

Blood (2025) 146 (Supplement 1): 934.

https://doi.org/10.1182/blood-2025-934

Published: 2025

Journal Articles

Incidence, patterns, and outcomes of adenovirus infections in patients following allogeneic hematopoietic cell transplantation

Areeba Ismail, Amna Bint I Munir, Fatima Imran, Muhammad Shahzou Shah, Zunaira Amjad, Muhammad Zeeshan, Hammad Shafi, Muhammad Kashif Amin, Joseph McGuirk, Moazzam Shahzad, Muhammad Umair Mushtaq

Blood (2025) 146 (Supplement 1): 7733.

https://doi.org/10.1182/blood-2025-7733

Published: 2025

Journal Articles

Efficacy, quality of life, and safety of non-clotting factor prophylaxis in Hemophilia A and b: A meta-analysis across inhibitor status

Abdul basit Khan, Rehan Ishaque, Sibgha Fawad Memon, Zauha fawad Memon, Matia Fawad Memon, Fawad Talat, Aswanth Reddy, Madhuri yalamanchili, Muhammad Kashif Amin, Muhammad Umair Mushtaq, Moazzam Shahzad, Supratik Rayamajhi

Blood (2025) 146 (Supplement 1): 6628.

https://doi.org/10.1182/blood-2025-6628

Published: 2025

Journal Articles

Outcomes and associated factors after melphalan 140 mg/m² autologous hematopoietic cell transplantation for multiple myeloma in patients over 70 years of age

Aqeeb Ur Rehman, Moazzam Shahzad, Shah Rukh, Zeeshan Sattar, Muhammad Kashif Amin, Jeries Kort, Al-Ola Abdallah, Leyla Shune, Mehdi Hamadani, Joseph McGuirk, Muhammad Umair Mushtaq

Blood (2025) 146 (Supplement 1): 5985.

https://doi.org/10.1182/blood-2025-5985

Published: 2025

Journal Articles

Impact of conditioning intensity on outcomes after unrelated donor hematopoietic cell transplantation using posttransplant cyclophosphamide-based GVHD prophylaxis

Muhammad Kashif Amin, Moazzam Shahzad, Amir Kasaeian, Hediyeh Alemi, Asma Zakir, Haitham Abdelhakim, Anurag Singh, Mehdi Hamadani, Joseph McGuirk, Muhammad Umair Mushtaq

Blood (2025) 146 (Supplement 1): 505.

https://doi.org/10.1182/blood-2025-505

Published: 2025

Journal Articles

Outcomes with dasatinib in Philadelphia Chromosome–Positive acute lymphoblastic leukemia: A systematic review and meta-analysis

Muhammad Kashif Amin, Hafiz Muhammad Hannan Javed, Zeeshan Sattar, Hafsa Shahid, Mamoon Ahmed, Aman Ullah, Aminah Tayyab, Waleeh Ahmed Mir, Ruhma Sehar, Muhammad Umair Mushtaq, Moazzam Shahzad

Blood (2025) 146 (Supplement 1): 6869.

https://doi.org/10.1182/blood-2025-6869

Published: 2025

Journal Articles

Outcomes of haploidentical hematopoietic stem cell transplantation in low- and middle-income countries: A systematic review and meta-analysis.

Moazzam Shahzad, Muhammad Kashif Amin, Rehan Ishaque, Mahad Zamir, Muhammad Junaid Azhar, Syed Aftab Haider Kamran, Muhammad Abdullah, Roma Bai, Ammara Saleem, Hammad Shafi, Raheel Iftikhar, Joseph McGuirk, Muhammad Umair Mushtaq

Blood (2025) 146 (Supplement 1): 7816.

https://doi.org/10.1182/blood-2025-7816

Published: 2025

Journal Articles

Single-arm meta-analysis of melflufen-based regimens in relapsed/refractory multiple myeloma: Efficacy and safety insights from clinical trials

Abdul basit Khan, Fawad Talat, Zauha fawad Memon, Rehan Ishaque, Sibgha Fawad Memon, Matia Fawad Memon, Hira Rehman, Hamza Janjua, Aswanth Reddy, Muhammad Umair Mushtaq, Muhammad Kashif Amin, Moazzam Shahzad

Blood (2025) 146 (Supplement 1): 7568.

https://doi.org/10.1182/blood-2025-7568

Published: 2025

Journal Articles

Outcomes with chimeric antigen receptor-t cell therapy in relapsed/refractory b-cell acute lymphoblastic leukemia: A systematic review and meta-analysis

Hafiz Muhammad Hannan Javed, Muhammad Kashif Amin, Hafsa Shahid, Sarmad Zaman Warraich, Muhammad Umair Mushtaq, Moazzam Shahzad

Blood (2025) 146 (Supplement 1): 6875.

https://doi.org/10.1182/blood-2025-6875

Published: 2025

Journal Articles

Outcomes with ponatinib in patients with relapsed/refractory Philadelphia-chromosome positive acute lymphoblastic leukemia: A systematic review and meta-analysis

Hafiz Muhammad Hannan Javed, Muhammad Kashif Amin, Zeeshan Sattar, Mamoon Ahmed, Aman Ullah, Aminah Tayyab, Waleeh Ahmed Mir, Fatima Sial, Ruhma Sehar, Muhammad Umair Mushtaq, Moazzam Shahzad

Blood (2025) 146 (Supplement 1): 6873.

https://doi.org/10.1182/blood-2025-6873

Published: 2025

Journal Articles

Comparative trends in mortality from acute lymphoblastic and Acute Myeloid Leukemia in the United States: A CDC wonder analysis (1999–2020)

Zauha fawad Memon, Sibgha Fawad Memon, Rehan Ishaque, Sarmad Masaud, Matia Fawad Memon, Amna Ikram, Shajadi Patan, Furqan Tarique Memon, Muhammad Kashif Amin, Joseph McGuirk, Moazzam Shahzad, Muhammad Umair Mushtaq

Blood (2025) 146 (Supplement 1): 4619.

https://doi.org/10.1182/blood-2025-4619

Published: 2025

Journal Articles

The role of high-dose vitamin c in management of hematological malignancies: Asystematic review and meta-analysis

Zeeshan Sattar, Muhammad Kashif Amin, Hafiz Muhammad Hannan Javed, Amir Kasaeian, Iman Menbary, Ruhma Sehar, Muhammad Umair Mushtaq, Moazzam Shahzad

Blood (2025) 146 (Supplement 1): 8116.

https://doi.org/10.1182/blood-2025-8116

Published: 2025

Journal Articles

“comparative outcomes of midline versus peripheral intravenous catheters: A systematic review and meta-analysis.”

Misbah Uddin, Muhammad Shaheer Bin Faheem, Sai Sushrutha Mudupula Vemula, Asim Shah, Asad Jamal, Suleman Khan, Aizaz Anwer Khalid, Hammad Iftikhar, FNU Sawaira, Muhammad Kashif, Muhammad Rehan Zahid

Blood (2025) 146 (Supplement 1): 7912.

https://doi.org/10.1182/blood-2025-7912

Published: 2025

Journal Articles

Mortality trends of chronic lymphocytic leukemia and pneumonia in the United States (1999–2023): A CDC-wonder analysis

Sibgha Fawad Memon, Zauha fawad Memon, Abdul basit Khan, Rehan Ishaque, Matia Fawad Memon, Abdul Subhan Talpur, Fawad Talat, Muhammad Shaheer Mannan, Aswanth Reddy, Muhammad Kashif Amin, Muhammad Umair Mushtaq, Moazzam Shahzad, Supratik Rayamajhi

Blood (2025) 146 (Supplement 1): 6269.

https://doi.org/10.1182/blood-2025-6269

Published: 2025

Journal Articles

Outcomes of allogeneic hematopoietic cell transplantation in myelofibrosis using post-transplant cyclophosphamide-based gvhd prophylaxis

Moazzam Shahzad, Aqeeb Ur Rehman, Aroog Khaliq, Muhammad Kashif Amin, Jordan Leal, Olivia Molander, Philip Lubanski, Maggie Nelson, Abdulraheem Yacoub, Anurag Singh, Mehdi Hamadani, Joseph McGuirk, Muhammad Umair Mushtaq

Blood (2025) 146 (Supplement 1): 2460.

https://doi.org/10.1182/blood-2025-2460

Published: 2025

Journal Articles

Outcomes with azacitidine versus decitabine in AML/MDS

Syed Maaz Tariq, Hafsa Shahid, Aminah Tayyab, Ammad Naeem, Zeeshan Sattar, Muhammad Shaheer Mannan, Atif Butt, Muhammad Kashif Amin, Moazzam Shahzad

Blood (2025) 146 (Supplement 1): 7377.

https://doi.org/10.1182/blood-2025-7377

Published: 2025

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

Comparative safety and efficacy of bendamustine versus fludarabine/cyclophosphamide prior to chimeric antigen receptor- T cell therapy: A systematic review and meta-analysis

Impact of early bacteremia on clinical outcomes following allogeneic hematopoietic cell transplantation with post-transplant cyclophosphamide-based gvhd prophylaxis

Impact of donor age on transplant outcomes in unrelated allogeneic hematopoietic stem cell transplantation using post-transplant cyclophosphamide-based gvhd prophylaxis

Tumor-infiltrating lymphocyte therapy in lung cancer: A systematic review

Outcomes after bone marrow versus peripheral blood mismatched unrelated donor hematopoietic cell transplantation using posttransplant cyclophosphamide-based GVHD prophylaxis

Incidence, patterns, and outcomes of adenovirus infections in patients following allogeneic hematopoietic cell transplantation

Efficacy, quality of life, and safety of non-clotting factor prophylaxis in Hemophilia A and b: A meta-analysis across inhibitor status

Outcomes and associated factors after melphalan 140 mg/m² autologous hematopoietic cell transplantation for multiple myeloma in patients over 70 years of age

Impact of conditioning intensity on outcomes after unrelated donor hematopoietic cell transplantation using posttransplant cyclophosphamide-based GVHD prophylaxis

Outcomes with dasatinib in Philadelphia Chromosome–Positive acute lymphoblastic leukemia: A systematic review and meta-analysis

Outcomes of haploidentical hematopoietic stem cell transplantation in low- and middle-income countries: A systematic review and meta-analysis.

Single-arm meta-analysis of melflufen-based regimens in relapsed/refractory multiple myeloma: Efficacy and safety insights from clinical trials

Outcomes with chimeric antigen receptor-t cell therapy in relapsed/refractory b-cell acute lymphoblastic leukemia: A systematic review and meta-analysis

Outcomes with ponatinib in patients with relapsed/refractory Philadelphia-chromosome positive acute lymphoblastic leukemia: A systematic review and meta-analysis

Comparative trends in mortality from acute lymphoblastic and Acute Myeloid Leukemia in the United States: A CDC wonder analysis (1999–2020)

The role of high-dose vitamin c in management of hematological malignancies: Asystematic review and meta-analysis

“comparative outcomes of midline versus peripheral intravenous catheters: A systematic review and meta-analysis.”

Mortality trends of chronic lymphocytic leukemia and pneumonia in the United States (1999–2023): A CDC-wonder analysis

Outcomes of allogeneic hematopoietic cell transplantation in myelofibrosis using post-transplant cyclophosphamide-based gvhd prophylaxis

Outcomes with azacitidine versus decitabine in AML/MDS

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only